A Tampa, Florida marathoner tackled the Dopey Challenge recently. Which is impressive enough, as the Dopey Challenge consists of running a 5K, 10K, Half marathon and Full marathon in successive days for a total of 48.6 miles. However, Florida marathoner, Ron Wertley, completed the marathon while undergoing chemotherapy treatments for cancer.
Mr. Wertley was first diagnosed with Acute Lymphoblastic Leukemia after completing the Dopey Challenge in 2018. Acute Lymphoblastic Leukemia is a type of cancer of the blood and bone marrow. Ron was given a 40-percent survival chance. Ron has competed in the RunDisney Dopey Challenge since 2014, raising more than $22,000 for the Leukemia & Lymphoma Society’s (LLS) Team in Training. Ron was determined to keep his “perfect” status of completing the challenge and made the decision to train while undergoing treatments.
Unfortunately, this decision didn’t come with a few challenges of its own. After almost a year of aggressive chemo treatments, which sent the cancer into remission, the cancer returned in December. Ron then began the challenge of a 30-day stint in the hospital and an aggressive chemo regimen to combat the disease. With the support of his 420 LLS Team in Training teammates, Ron was able to complete his sixth Dopey Challenge. Which shows his sheer determination to do what he loves!
Source: Disney Parks Blog
Are you wishing you could be a part of the Magic? Pack your bags and get ready to go! As an agent that specializes in Disney Destinations, and the official travel partner for Chip and Co, I can help you begin your journey. Just click the Key to the World Travel Picture, email me at Jessica.firstname.lastname@example.org, follow on Facebook or fill out the form below for a free no-obligation quote.
Latest posts by Jessica Jones (see all)
- Sneak Peek of New Character Art to Count Down to Villains After Hours. - April 24, 2019
- Pop-Up Dress Shop at the Marketplace Co-Op for Dapper Day. - April 24, 2019
- Black Tap Craft Burgers & Shakes Opening at Downtown Disney. - April 23, 2019